Development of Korean Rare Disease Knowledge Base.
10.4258/hir.2012.18.4.272
- Author:
Heewon SEO
1
;
Dokyoon KIM
;
Jong Hee CHAE
;
Hee Gyung KANG
;
Byung Chan LIM
;
Hae Il CHEONG
;
Ju Han KIM
Author Information
1. Seoul National University Biomedical Informatics (SNUBI), Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Korea. juhan@snu.ac.kr
- Publication Type:Clinical Trial ; Original Article
- Keywords:
Rare Diseases;
Knowledge Bases;
Korean;
Genetic Databases;
Online Systems
- MeSH:
Databases, Genetic;
Humans;
Information Storage and Retrieval;
Knowledge Bases;
Korea;
Online Systems;
Rare Diseases
- From:Healthcare Informatics Research
2012;18(4):272-278
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: Rare disease research requires a broad range of disease-related information for the discovery of causes of genetic disorders that are maladies caused by abnormalities in genes or chromosomes. A rarity in cases makes it difficult for researchers to elucidate definite inception. This knowledge base will be a major resource not only for clinicians, but also for the general public, who are unable to find consistent information on rare diseases in a single location. METHODS: We design a compact database schema for faster querying; its structure is optimized to store heterogeneous data sources. Then, clinicians at Seoul National University Hospital (SNUH) review and revise those resources. Additionally, we integrated other sources to capture genomic resources and clinical trials in detail on the Korean Rare Disease Knowledge base (KRDK). RESULTS: As a result, we have developed a Web-based knowledge base, KRDK, suitable for study of Mendelian diseases that commonly occur among Koreans. This knowledge base is comprised of disease summary and review, causal gene list, laboratory and clinic directory, patient registry, and so on. Furthermore, database for analyzing and giving access to human biological information and the clinical trial management system are integrated on KRDK. CONCLUSIONS: We expect that KRDK, the first rare disease knowledge base in Korea, may contribute to collaborative research and be a reliable reference for application to clinical trials. Additionally, this knowledge base is ready for querying of drug information so that visitors can search a list of rare diseases that is relative to specific drugs. Visitors can have access to KRDK via http://www.snubi.org/software/raredisease/.
